Bristol Myers Squibb plans to invest $40 billion in the U.S. over the next five years to strengthen its research and manufacturing capabilities, reported Reuters. The investment will include R&D, technology advancements, and enhancing U.S. manufacturing capacity as part of an effort to gain better control over complex supply chains and to align manufacturing with R&D activities in the U.S. The investment plan follows the company’s recent agreement to acquire its cell therapy ...